Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA

Patient- and prescriber-level characteristics appear to be associated with patient outcomes following buprenorphine treatment for opioid use disorder. In particular, patients' race/ethnicity and insurance coverage appear to be associated with substantial disparities in outcomes, and prescriber characteristics appear to be most closely associated with medication continuity during early treatment.

Authors

Institutions

Publication Details

Journal
Addiction
Published
2024-10-13
DOI
https://doi.org/10.1111/add.16684
Citations
6
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
3.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA

Gary J. Young, Leonard D. Young, Md. Noor‐E‐Alam, Farbod Alinezhad et al.
6 citations
Addiction
Opioid Use Disorder Treatment
3.26
article

Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA

Gary J. Young, Leonard D. Young, Md. Noor‐E‐Alam, Farbod Alinezhad, Md Mahmudul Hasan, Tianjie Zhu
article en
6 citations

Abstract

Patient- and prescriber-level characteristics appear to be associated with patient outcomes following buprenorphine treatment for opioid use disorder. In particular, patients' race/ethnicity and insurance coverage appear to be associated with substantial disparities in outcomes, and prescriber characteristics appear to be most closely associated with medication continuity during early treatment.

AddictionVol. 120(1)
Northeastern University (US), Massachusetts Department of Public Health (US), University of Florida (US)
Centers for Disease Control and Prevention
No poverty
Openalex Percentile: Top 8%
Opioid Use Disorder Treatment
3.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.